Am J Health Syst Pharm. 2006;63(11):1022-1028. Q: How can potential medication errors be minimized when dispensing investigational drugs to better ensure patient safety and improve adherence to the ...

Patients, providers, manufacturers, and pharmacies are typically in agreement that when prescribed a specialty medication, starting a patient on that therapy should be a top priority. Unfortunately, ...

Vanilla-looking form agreements may contain or omit terms that are important to one or both parties. We were recently reminded of the danger of entering into form pharmaceutical distribution services ...

Eli Lilly (the company behind Mounjaro and Zepbound) just announced impressive phase 3 clinical trial results for a new weight loss medication, orforglipron, a GLP-1. Orforglipron is an oral ...